ZipBio

About:

ZipBio develops next-gen gene therapies using machine learning, protein engineering, and molecular materials.

Website: https://www.ziptx.bio

Twitter/X: ZipBio_Inc

Top Investors: NFX, MoreVC

Description:

ZipBio focuses on compressing biology to develop the next generation of gene therapies. The company leverages machine learning, protein engineering, and molecular materials to create innovative therapeutic solutions. As a biotechnology firm, ZipBio aims to advance the field of synthetic biology and self-assembly techniques to address complex medical challenges.

Total Funding Amount:

$4M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2022-09-01

Contact Email:

contact(AT)ziptx.bio

Founders:

Roee Farber

Number of Employees:

1-10

Last Funding Date:

2024-09-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai